215 related articles for article (PubMed ID: 26265409)
1. Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.
Iversen LV; Ullman S; Østergaard O; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
BMC Musculoskelet Disord; 2015 Aug; 16():191. PubMed ID: 26265409
[TBL] [Abstract][Full Text] [Related]
2. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
3. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
[TBL] [Abstract][Full Text] [Related]
4. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Yalçinkaya Y; Çinar S; Artim-Esen B; Kamali S; Öcal L; Deniz G; Inanç M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):110-114. PubMed ID: 27749243
[TBL] [Abstract][Full Text] [Related]
5. Increased serum levels of fractalkine and mobilisation of CD34
Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
[TBL] [Abstract][Full Text] [Related]
6. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis.
Ateş A; Kinikli G; Turgay M; Duman M
Scand J Immunol; 2004 Mar; 59(3):315-20. PubMed ID: 15030584
[TBL] [Abstract][Full Text] [Related]
7. Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.
Lau YC; Xiong Q; Blann AD; Lip GY
J Thromb Thrombolysis; 2017 Jan; 43(1):18-23. PubMed ID: 27671694
[TBL] [Abstract][Full Text] [Related]
8. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
[TBL] [Abstract][Full Text] [Related]
9. Platelet Phagocytosis via P-selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis.
Manfredi AA; Ramirez GA; Godino C; Capobianco A; Monno A; Franchini S; Tombetti E; Corradetti S; Distler JHW; Bianchi ME; Rovere-Querini P; Maugeri N
Arthritis Rheumatol; 2022 Feb; 74(2):318-328. PubMed ID: 34279048
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.
Kollert F; Christoph S; Probst C; Budweiser S; Bannert B; Binder M; Sehnert B; Voll RE; Warnatz K; Zissel G; Walker UA; Prasse A; Saalbach A
Arthritis Care Res (Hoboken); 2013 Feb; 65(2):281-7. PubMed ID: 22807289
[TBL] [Abstract][Full Text] [Related]
11. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
[TBL] [Abstract][Full Text] [Related]
12. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
15. Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Ogawa F; Takahashi H; Tanaka S; Sato S; Takehara K
PLoS One; 2014; 9(2):e88150. PubMed ID: 24516598
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
17. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
18. Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases.
Sfikakis PP; Charalambopoulos D; Vaiopoulos G; Mavrikakis M
Clin Rheumatol; 1999; 18(1):28-32. PubMed ID: 10088945
[TBL] [Abstract][Full Text] [Related]
19. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]